What are Ligand Pharmaceuticals's profit margins?

Ligand Pharmaceuticals (LGND) runs a 91.9% gross margin and a 34.5% operating margin, with a 55.9% net margin.

Where do Ligand Pharmaceuticals's ratios come from?

Every ratio is computed from Ligand Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Ligand Pharmaceuticals LGND Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Profitability
Operating margin	15.3%+28.8pp	-13.5%—	——	——
Net margin	46.4%+48.8pp	-2.4%-42.1pp	39.7%+56.7pp	-17%-40.7pp
EBITDA margin	27.9%+20.3pp	7.6%-45.0pp	52.6%+2.1pp	50.5%-13.7pp
Free cash flow margin	18.2%-38.7pp	57%+21.7pp	35.3%-25.8pp	61.1%+32.1pp
Returns
Return on equity	13.5%+14.0pp	-0.5%-8.6pp	8%+12.7pp	-4.7%-12.2pp
Return on assets	9.9%+10.4pp	-0.5%-7.2pp	6.7%+10.0pp	-3.2%-7.5pp
Return on invested capital	4%+7.1pp	-3.1%-8.0pp	4.9%+1.7pp	3.3%-10.6pp
Efficiency
Asset turnover	0.2×0.0×	0.2×0.0×	0.2×0.0×	0.2×0.0×
Liquidity
Current ratio	22.2×+13.3×	8.9×-5.2×	14.1×+11.5×	2.7×-8.5×
Quick ratio	22×+13.4×	8.6×-4.2×	12.7×+10.2×	2.5×-8.0×
Cash ratio	4.7×+2.7×	1.9×+0.6×	1.4×+0.9×	0.5×0.0×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×-0.1×	0.1×+0.1×
Debt-to-assets	0×0.0×	0×0.0×	0×-0.1×	0.1×+0.1×
Net debt / EBITDA	-2.3×+2.9×	-5.2×-4.9×	-0.2×-0.7×	0.4×+0.4×
Interest coverage	8.7×+16.1×	-7.5×-57.0×	49.6×+23.2×	26.4×+21.1×
Per Share
Book value per share	$50.12+10.4%	$45.40+15.0%	$39.47+11.4%	$35.42-27.8%
Valuation
Market capitalization	$3.72B+83.8%	$2.02B+62.6%	$1.25B+10.3%	$1.13B-56.3%
Enterprise value	$3.55B+81.3%	$1.96B+59.5%	$1.23B+4.9%	$1.17B-54.6%
Price / earnings	29.9×—	——	23.9×—	——
Price / sales	13.9×+1.8×	12.1×+2.6×	9.5×+3.7×	5.8×-4.9×
Price / book	3.7×+1.2×	2.4×+0.7×	1.8×-0.1×	1.9×-1.3×
EV / EBITDA	47.5×-108×	155.1×+137×	17.8×+6.0×	11.8×-4.8×
EV / sales	13.2×+1.5×	11.7×+2.4×	9.4×+3.4×	6×-4.7×
Free cash flow yield	1.3%-3.4pp	4.7%+1.0pp	3.7%-6.9pp	10.6%+7.9pp
Earnings yield	3.3%+3.5pp	-0.2%-4.4pp	4.2%+7.1pp	-3%-5.2pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Ligand Pharmaceuticals's profit margins?: Ligand Pharmaceuticals (LGND) runs a 91.9% gross margin and a 34.5% operating margin, with a 55.9% net margin.
Where do Ligand Pharmaceuticals's ratios come from?: Every ratio is computed from Ligand Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.